Interleukin 6 inhibits HBV entry through NTCP down regulation (Q41435030)

30 September 2017

Interleukin 6 inhibits HBV entry through NTCP down regulation (English)

1 reference

30 September 2017

Fidaa Bouezzedine

1

1 reference

30 September 2017

Olivier Fardel

series ordinal

2

1 reference

30 September 2017

Philippe Gripon

series ordinal

3

1 reference

30 September 2017

language of work or name

English

0 references

publication date

9 March 2015

1 reference

30 September 2017

1 reference

30 September 2017

481

1 reference

30 September 2017

34-42

1 reference

Early kinetics of innate and adaptive immune responses during hepatitis B virus infection

30 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.02.026

Principles of hepatic organic anion transporter regulation during cholestasis, inflammation and liver regeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.02.026

Efficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.02.026

Reproducible high level infection of cultured adult human hepatocytes by hepatitis B virus: effect of polyethylene glycol on adsorption and penetration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.02.026

Myristylation of the hepatitis B virus large surface protein is essential for viral infectivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.02.026

Infection of a human hepatoma cell line by hepatitis B virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.02.026

Not interferon, but interleukin-6 controls early gene expression in hepatitis B virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.02.026

Role of liver-enriched transcription factors and nuclear receptors in regulating the human, mouse, and rat NTCP gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.02.026

High cleavage efficiency of a 2A peptide derived from porcine teschovirus-1 in human cell lines, zebrafish and mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.02.026

Successful tocilizumab treatment in a patient with adult-onset Still's disease complicated by chronic active hepatitis B and amyloid A amyloidosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.02.026

A systematic comparison of the impact of inflammatory signaling on absorption, distribution, metabolism, and excretion gene expression and activity in primary human hepatocytes and HepaRG cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.02.026

HBV replication is significantly reduced by IL-6.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.02.026

Down-regulation of organic anion transporter expression in human hepatocytes exposed to the proinflammatory cytokine interleukin 1beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.02.026

Regulation of drug transporter expression by oncostatin M in human hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.02.026

Differential regulation of drug transporter expression by hepatocyte growth factor in primary human hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.02.026

Regulation of drug transporter expression in human hepatocytes exposed to the proinflammatory cytokines tumor necrosis factor-alpha or interleukin-6.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.02.026

The first transmembrane domain of the hepatitis B virus large envelope protein is crucial for infectivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.02.026

Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.02.026

Hepatitis B virus requires intact caveolin-1 function for productive infection in HepaRG cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.02.026

Fine mapping of virus-neutralizing epitopes on hepatitis B virus PreS1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.02.026

Characterization of novel safe lentiviral vectors derived from simian immunodeficiency virus (SIVmac251) that efficiently transduce mature human dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.02.026

Serum interleukin 6 level correlates with outcomes of acute exacerbation of chronic hepatitis B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.02.026

Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.02.026

Hepatocyte polarization is essential for the productive entry of the hepatitis B virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.02.026

Hepatitis B virus biology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.02.026

Circulating proinflammatory cytokines (IL-1 beta, TNF-alpha, and IL-6) and IL-1 receptor antagonist (IL-1Ra) in fulminant hepatic failure and acute hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.02.026

Induction of a Striking Systemic Cytokine Cascade prior to Peak Viremia in Acute Human Immunodeficiency Virus Type 1 Infection, in Contrast to More Modest and Delayed Responses in Acute Hepatitis B and C Virus Infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.02.026

Elevated serum interleukin-6 levels in patients with acute hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.02.026

IL-6 Promotes compensatory liver regeneration in cirrhotic rat after partial hepatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.02.026

Serum levels of interleukin-1 alpha, interleukin-1 beta, interleukin-6, and tumor necrosis factor in patients with acute viral hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.02.026

Strategies to inhibit entry of HBV and HDV into hepatocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.02.026

Interleukin-1 and tumor necrosis factor-α trigger restriction of hepatitis B virus infection via a cytidine deaminase activation-induced cytidine deaminase (AID)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.02.026

Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.02.026

Stealth and cunning: hepatitis B and hepatitis C viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.02.026

Serum cytokine/chemokine profiles in acute exacerbation of chronic hepatitis B: clinical and mechanistic implications.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.02.026

Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.02.026

Hepatitis B virus infection of adult human hepatocytes cultured in the presence of dimethyl sulfoxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.02.026

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIROL.2015.02.026

1 reference

30 September 2017

1 reference